ZKSCAN5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.421400E-01
Normal-vs-Stage2
9.471600E-01
Normal-vs-Stage3
8.248000E-02
Normal-vs-Stage4
4.996800E-01
Stage1-vs-Stage2
6.541800E-01
Stage1-vs-Stage3
4.262100E-02
Stage1-vs-Stage4
6.784800E-01
Stage2-vs-Stage3
1.112370E-01
Stage2-vs-Stage4
4.561800E-01
Stage3-vs-Stage4
4.215900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.393200E-01
Normal-vs-AfricanAmerican
5.498000E-01
Normal-vs-Asian
3.886000E-01
Caucasian-vs-AfricanAmerican
2.781600E-01
Caucasian-vs-Asian
3.492200E-01
AfricanAmerican-vs-Asian
8.175600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.084000E-01
Normal-vs-Female
9.386000E-01
Male-vs-Female
2.967200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.844600E-01
Normal-vs-Age(41-60Yrs)
6.403800E-01
Normal-vs-Age(61-80Yrs)
6.107200E-01
Normal-vs-Age(81-100Yrs)
5.103000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.324400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.601240E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.125050E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.620000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.576090E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.524600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.873600E-01
Normal-vs-Daily Drinker
5.536000E-01
Normal-vs-Weekly Drinker
7.256400E-01
Normal-vs-Occasional Drinker
7.953600E-01
Normal-vs-Social Drinker
5.497200E-01
Non Drinker-vs-Daily Drinker
3.735000E-01
Non Drinker-vs-Weekly Drinker
2.837400E-01
Non Drinker-vs-Occasional Drinker
1.388390E-01
Non Drinker-vs-Social Drinker
2.701700E-03
Daily Drinker-vs-Weekly Drinker
7.595000E-01
Daily Drinker-vs-Occasional Drinker
2.609800E-01
Daily Drinker-vs-Social Drinker
3.595900E-02
Weekly Drinker-vs-Occasional Drinker
3.554000E-01
Weekly Drinker-vs-Social Drinker
1.320400E-01
Occasional Drinker-vs-Social Drinker
9.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.035010E-01
Normal-vs-Grade 2
1.141990E-02
Normal-vs-Grade 3
1.362230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.589800E-01
Grade 1-vs-Grade 3
6.428400E-02
Grade 1-vs-Grade 4
1.035010E-01
Grade 2-vs-Grade 3
3.901600E-02
Grade 2-vs-Grade 4
1.141990E-02
Grade 3-vs-Grade 4
1.362230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.747800E-01
Normal-vs-NonDiabetic
9.630400E-01
Diabetic-vs-NonDiabetic
6.838000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.545600E-01
Normal-vs-NoPancreatitis
8.841800E-01
Pancreatitis-vs-NoPancreatitis
8.366000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.452200E-01
Normal-vs-N1
9.976400E-01
N0-vs-N1
3.414200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.111000E-01
Normal-vs-TP53-NonMutant
9.488600E-01
TP53-Mutant-vs-TP53-NonMutant
2.040800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
